Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes

NCT02551315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2022-12-22

No results posted yet for this study

Summary

This multicenter, prospective, observational cohort study will assess bone differences in women and men with type 2 diabetes mellitus (T2DM) with and without fragility fractures.

Conditions

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Christian Meier, Prof. MD · University Hospital, Basel, Switzerland

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-01-10
Completion
2020-01-10

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02551315 on ClinicalTrials.gov